MICROBOT MEDICAL INC. news, videos and press releases
For more news please use our advanced search feature.
MICROBOT MEDICAL INC. - More news...
MICROBOT MEDICAL INC. - More news...
- Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
- REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
- Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
- Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
- Microbot Medical Closes $13 Million Registered Direct Offering
- Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
- Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®
- Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
- Microbot Medical Closes $8.6 Million Registered Direct Offering
- Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
- Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
- Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
- Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
- Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
- Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
- Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
- Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
- Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
- Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
- Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
- Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
- Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
- Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
- Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
- Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
- Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
